Your browser doesn't support javascript.
loading
Corrigendum to 'clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome'.
Scholl, Suzy; Popovic, Marina; Rochefordiere, Anne de la; Girard, Elodie; Dureau, Sylvain; Mandic, Aljosa; Koprivsek, Katarina; Samet, Nina; Craina, Marius; Margan, Madalin; Samuels, Sanne; Zijlmans, Henry; Kenter, Gemma; Hillemanns, Peter; Dema, Sorin; Dema, Alis; Malenkovic, Goran; Djuran, Branislav; Floquet, Anne; Garbay, Delphine; Guyon, Frédéric; Colombo, Pierre Emmanuel; Fabbro, Michel; Kerr, Christine; Ngo, Charlotte; Lecuru, Fabrice; Del Campo, Eleonor Rivin; Coutant, Charles; Marchal, Frédéric; Mesgouez-Nebout, Nathalie; Fourchotte, Virginie; Feron, Jean Guillaume; Morice, Philippe; Deutsch, Eric; Wimberger, Pauline; Classe, Jean-Marc; Gleeson, Noreen; Leyen, Heiko von der; Minsat, Mathieu; Dubot, Coraline; Gestraud, Pierre; Kereszt, Attila; Nagy, Istvan; Balint, Balazs; Berns, Els; Jordanova, Ekaterina; de Saint-Jorre, Nicolas; Savignoni, Alexia; Servant, Nicolas; Hupe, Philippe.
Afiliación
  • Scholl S; Institut Curie, PSL Research University, Department of Drug Development and Innovation, France. Electronic address: suzy.scholl@curie.fr.
  • Popovic M; Gynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia.
  • Rochefordiere A; Institut Curie, PSL Research University, Department of Drug Development and Innovation, France.
  • Girard E; Institut Curie, PSL Research University, Department of Drug Development and Innovation, France.
  • Dureau S; Institut Curie, PSL Research University, Department of Drug Development and Innovation, France.
  • Mandic A; Faculty of Medicine Novi Sad, University of Novi Sad, Serbia.
  • Koprivsek K; Gynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia; Faculty of Medicine Novi Sad, University of Novi Sad, Serbia.
  • Samet N; Publica Institutul Oncologic, Republic of Moldova.
  • Craina M; University of Medicine and Pharmacy "Victor Babeș", Romania.
  • Margan M; University of Medicine and Pharmacy "Victor Babeș", Romania.
  • Samuels S; Center for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Zijlmans H; Center for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Kenter G; Center for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Hillemanns P; Hannover Medical School, Germany.
  • Dema S; University of Medicine and Pharmacy "Victor Babeș", Romania.
  • Dema A; University of Medicine and Pharmacy "Victor Babeș", Romania.
  • Malenkovic G; Faculty of Medicine Novi Sad, University of Novi Sad, Serbia.
  • Djuran B; Gynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia.
  • Floquet A; Chirurgie onco-gynécologique and Oncology, Institut Bergonié, Centre Régional de Lutte contre le Cancer Bordeaux-Aquitaine, France.
  • Garbay D; Chirurgie onco-gynécologique and Oncology, Institut Bergonié, Centre Régional de Lutte contre le Cancer Bordeaux-Aquitaine, France.
  • Guyon F; Chirurgie onco-gynécologique and Oncology, Institut Bergonié, Centre Régional de Lutte contre le Cancer Bordeaux-Aquitaine, France.
  • Colombo PE; Centre Val d'Aurelle, France.
  • Fabbro M; Centre Val d'Aurelle, France.
  • Kerr C; Centre Val d'Aurelle, France.
  • Ngo C; Service de chirurgie cancérologique gynécologique et du sein, Hôpital Européen Georges Pompidou, APHP et faculté de médecine, Université Paris Descartes, France.
  • Lecuru F; Service de chirurgie cancérologique gynécologique et du sein, Hôpital Européen Georges Pompidou, APHP et faculté de médecine, Université Paris Descartes, France.
  • Del Campo ER; Department of Radiation Oncology, Tenon University Hospital, Hôpitaux Universitaires Est Parisien, Sorbonne University Medical Faculty, Paris, France.
  • Coutant C; Centre Georges François Leclerc, France.
  • Marchal F; Département de chirurgie, CRAN, UMR 7039, Université de Lorraine, CNRS, Institut de Cancérologie de Lorraine, 6 avenue de Bourgogne - CS 30519 54519, Vandoeuvre-les-Nancy Cedex, France.
  • Mesgouez-Nebout N; Institut de cancérologie de l'Ouest - site Paul Papin (ICO) 15, Rue André Boquel, 49055 Angers, France.
  • Fourchotte V; Institut Curie, PSL Research University, Department of Drug Development and Innovation, France.
  • Feron JG; Institut Curie, PSL Research University, Department of Drug Development and Innovation, France.
  • Morice P; Gustave Roussy, France.
  • Deutsch E; Gustave Roussy, France.
  • Wimberger P; Department of Gynecology and Obstetrics, Universitätsklinikum Carl Gustav Carus; an der Technischen Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany.
  • Classe JM; René Gauducheau, France.
  • Gleeson N; St James/Trinity College, Ireland.
  • Leyen HV; Hannover Clinical Trial Center GmbH, Germany.
  • Minsat M; Institut Curie, PSL Research University, Department of Drug Development and Innovation, France.
  • Dubot C; Institut Curie, PSL Research University, Department of Drug Development and Innovation, France.
  • Gestraud P; Institut Curie, PSL Research University, Department of Drug Development and Innovation, France.
  • Kereszt A; SeqOmics Biotechnology Ltd, Vallalkozok utja 7, Morahalom, Hungary.
  • Nagy I; SeqOmics Biotechnology Ltd, Vallalkozok utja 7, Morahalom, Hungary.
  • Balint B; SeqOmics Biotechnology Ltd, Vallalkozok utja 7, Morahalom, Hungary.
  • Berns E; Erasmus MC, The Netherlands.
  • Jordanova E; Center for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • de Saint-Jorre N; Quanticsoft, France.
  • Savignoni A; Institut Curie, PSL Research University, Department of Drug Development and Innovation, France.
  • Servant N; Institut Curie, PSL Research University, Department of Drug Development and Innovation, France.
  • Hupe P; Institut Curie, PSL Research University, Department of Drug Development and Innovation, France.
EBioMedicine ; 57: 102875, 2020 07.
Article en En | MEDLINE | ID: mdl-32650273
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: EBioMedicine Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: EBioMedicine Año: 2020 Tipo del documento: Article